$188 Million is the total value of Versant Venture Management, LLC's 8 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | RayzeBio, Inc. | $114,511,174 | – | 5,158,161 | +100.0% | 60.87% | – | |
| RPTX | Repare Therapeutics, Inc. | $31,971,617 | +14.2% | 2,646,657 | 0.0% | 17.00% | -48.8% | |
| CRSP | CRISPR Therapeutics AG | $22,629,548 | -19.1% | 498,558 | 0.0% | 12.03% | -63.8% | |
| ADVM | Adverum Biotechnologies, Inc. | $7,602,350 | -5.7% | 5,068,233 | 0.0% | 4.04% | -57.7% | |
| GRTS | Gritstone Oncology, Inc. | $6,125,178 | -11.8% | 3,561,150 | 0.0% | 3.26% | -60.5% | |
| PASG | Passage Bio, Inc. | $3,263,528 | -30.1% | 4,959,769 | 0.0% | 1.74% | -68.7% | |
| ALGS | Aligos Therapeutics, Inc. | $1,733,325 | -23.1% | 2,320,381 | 0.0% | 0.92% | -65.5% | |
| Sell | Minerva Surgical Inc. | $275,320 | -35.8% | 83,684 | -95.0% | 0.15% | -71.3% | |
| CBAY | Exit | CymaBay Therapeutics, Inc. | $0 | – | -543,753 | -100.0% | -7.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CymaBay Therapeutics, Inc. | 35 | Q2 2023 | 10.2% |
| Clovis Oncology, Inc. | 32 | Q3 2022 | 53.2% |
| CRISPR Therapeutics AG | 23 | Q3 2023 | 77.2% |
| Ocular Therapeutix, Inc. | 22 | Q4 2020 | 18.0% |
| Gritstone Oncology, Inc. | 18 | Q3 2023 | 25.4% |
| Achaogen, Inc. | 18 | Q1 2019 | 23.5% |
| Adverum Biotechnologies, Inc. | 15 | Q3 2023 | 21.0% |
| Second Sight Medical Products, Inc. | 15 | Q3 2020 | 9.0% |
| Audentes Therapeutics, Inc. | 13 | Q3 2019 | 39.6% |
| Aligos Therapeutics, Inc. | 12 | Q3 2023 | 15.7% |
View Versant Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-08 |
| 13F-HR | 2023-11-03 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-11 |
| 144 | 2023-04-20 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-11 |
View Versant Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.